Gerrit Voortman

Gerrit Voortman has extensive experience in the pharmaceutical and biotechnology industries, demonstrating a strong background in clinical development, regulatory affairs, and corporate development. Voortman has served as Vice President of Corporate Development and Vice President of Regulatory Affairs at Byondis since October 2014. Prior roles include Vice President of Clinical Development and Director of Medical R&D at Synthon, Owner of Drug & Device Development Consultancy (3DC), Chief Scientific Officer (Acting) at M et P Pharma, and Director of Clinical Research at Clinquest Europe BV. Additional experience includes positions at Medtronic, Organon, and Organon Pharmaceuticals, where Voortman managed development projects and clinical studies. Voortman holds a Master's degree in Toxicology from Open Universiteit, completed between 1988 and 1995.